Canadian Health Care Systems
|
|
|
- Maude Osborne
- 5 years ago
- Views:
Transcription
1 Vaccine Decisions: Policy Making and Priority Setting in Canadian Health Care Systems Charlotte Moore Hepburn, MD, FRCPC, FAAP Lead, Child Health Policy Initiative Faculty Pediatrician, Division of Pediatric Medicine, The Hospital for Sick Children Assistant Professor, Department of Pediatrics, University of Toronto School of Medicine
2 Objectives Structure of Canadian health care system Processes supporting evidence-informed policy Challenges with evidence-informed policy-making Realities of priority setting in publicly-funded health care systems
3 Canada
4 The Greatest Canadian
5 Canadian Constitution VI. DISTRIBUTION OF LEGISLATIVE POWERS ARTICLE 91: o Powers of the Parliament ARTICLE 92: o Exclusive Powers of the Provincial Legislatures
6 Canada
7 Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial
8 Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial/Territorial
9 Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial
10 Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial/Territorial
11 Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial
12 Recommendations for Use National Advisory Committee on Immunization (NACI) Federal All-volunteer, scientific advisory committee o o Experts in pediatrics, infectious disease, immunology, medical microbiology, internal medicine, public health Serve in disease-specific working groups Supported by the Public Health Agency of Canada Approached by manufacturers, governments, scientific community Offer recommendations for the use of vaccines currently or newly approved for use in humans in Canada o Including definition of vaccine schedules, catch-up schedules, and identification of at-risk groups for whom vaccine programs should be targeted
13 Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Scientific Recommendations Only No economic analysis No policy or program delivery-related recommendations No funding-related decision-making authority Aims to: o Influence clinical activities (noting medial-legal implications) o Influence P/T jurisdictions
14 Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial
15 Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Federal/Provincial/Territorial delegate body o Experts in public health and public health policy Supported by the Public Health Network Council, reporting to the F/P/T Deputy Ministers of Health Provides policy and program recommendations related to the implementation of publicly funded vaccine programs
16 Structured Approach to Policy and Program Analysis 16
17 Erickson-DeWals Criteria Burden of Disease Outstanding Research Vaccine Questions Characteristics Equity Strategy Selection Ethical Considerations Cost-Effectiveness Legal Considerations Acceptability Program Conformity Feasibility Political Considerations Capacity to Evaluate
18 Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Science into Policy Recommendations Provide economic analysis Provide policy and program delivery-related recommendations No funding-related decision-making authority Aims to: o o o Reduce duplication of effort across P/T jurisdictions Influence decisions of P/T jurisdictions Promote harmonization of immunization schedules across the country
19 Science Science-Informed Policy Advice NACI CIC Federal, all-volunteer expert body Scientific recommendations with scheduled public release Moral Authority National, F/P/T delegate body Policy and program recommendations consistent with F/P/T norms Enabled Collaboration No resource-allocation decision-making No formal linkage to vaccine procurement process
20 Science Science-Informed Policy Advice 13 Different Vaccine Schedules 13 Different Procurement Strategies
21 Science Science-Informed Policy Advice 13 Different Vaccine Schedules 13 Different Procurement Strategies
22 Decisions regarding Public Funding Ministries of Health Provincial/Territorial Hepatitis B: Birth, 1 month, 6 months First introduced 1995 Hepatitis B: Grade 4 First introduced 1998 Hepatitis B (DtaP-HB-IPV-Hib): 2 months, 4 months, 6 months First introduced 1992
23 Decisions regarding Public Funding Ministries of Health Provincial/Territorial ): 12 months No Rotavirus Vaccine Program Oral Rotavirus Vaccine: 2 months, 4 months
24 Decisions regarding Public Funding Ministries of Health Provincial/Territorial NACI Recommendation: ): 2 months, 4 months, 6 months 12 July months 2010 Statement No Rotavirus Vaccine Program Oral Rotavirus Vaccine: 2 months, 4 months
25 Three Streams 1 Problem Policy Politics Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.
26 Informing the Political Stream Evidence Platform Commitments Stakeholder Advocacy Legislative / Legal Imperative THE POLITICAL STREAM Resources Media Attention Public Expectations Time 1 1. Mitton, C et al. Difficult Decisions in Times of Constraint: Criteria based resource allocation in the Vancouver Coastal Health Authority. BMJ Health Services Research 2011; 11: 169
27 Three Streams 1 Problem NACI Policy CIC Politics Provincial Jurisdictions Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.
28 Three Streams 1 Problem NACI Policy CIC Politics Provincial Jurisdictions WINDOW OF OPPORTUNITY Occasional, Sudden, Brief Kingdon, JW. (1995) Agendas, Alternatives and Public Policies. Longman, London.
29 Vaccine Decisions (1) Approval for Use Health Canada (Biologics and Genetic Therapies Directorate) Federal Recommendations for Use National Advisory Committee on Immunization (NACI) Federal Recommendations for Policy and Program Development Canadian Immunization Committee (CIC) National (F/P/T) Decisions regarding Public Funding Ministries of Health Provincial/Territorial
30 Decisions regarding Public Funding Ministries of Health Provincial/Territorial Policy recommendations into policy Provincial / Territorial variation in o Burden of disease Differences in local epidemiology, populations and immigration patterns o Capacity to finance new vaccine programs Differences in provincial health priorities / pressures o Capacity to articulate policy case for new vaccine investment Differences in public health / health policy processes and resources o Capacity to implement new vaccine program Differences in vaccine delivery models Informed by P/T-level Vaccine Advisory Bodies (i.e. PIDAC)
31 Decisions regarding Public Funding Ministries of Health Provincial/Territorial Policy recommendations into policy Variation in o Burden of disease Differences in local epidemiology, populations and immigration patterns o Capacity to finance new vaccine programs Differences in provincial health priorities / pressures o Capacity to articulate policy case for new vaccine investment Differences in public health / health policy processes and resources o Capacity to implement new vaccine program Differences in vaccine delivery models
32 Willie Sutton School of Public Policy Safe, Effective and Cost Effective = Necessary Not Sufficient
33 Decisions regarding Public Funding Ministries of Health Provincial/Territorial ): 12 months Funded HPV Vaccination Programs
34 Priority Setting in Publicly Funded Health Systems New Vaccine Programs Capital Enhancements for Public Health Laboratories Enhanced Communicable Disease Surveillance Public Heath Priority Innovative Chronic Disease Prevention Programming Enhanced Breastfeeding Supports and Services Increased Food and Water Safety Protection Officers
35 Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Newborn Screening Services Child Heath System Priority Funding for Double Cochlear Implants Investment in School- Based Mental Health Services Improved Access to Level III NICU Care
36 Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Telemedicine Services to Remote Communities Heath System Priority Improved Access to Level III NICU Care Investment in System- Wide Electronic Health Records Reduced Wait Times for Joint Replacement Surgery
37 Priority Setting in Publicly Funded Health Systems New Vaccine Programs Expansion of Telemedicine Services to Remote Communities Heath System Priority Improved Access to Level III NICU Care Investment in System- Wide Electronic Health Records Reduced Wait Times for Joint Replacement Surgery
38 Priority Setting in Publicly Funded Health Systems New Vaccine Programs Creation of Affordable Public Housing System Priority Smaller Elementary School Class Sizes Investments in critical elements of transportation infrastructure New Job Training Programs for Seasonal Workers
39 Favorable Vaccine Environments Prosperous economic conditions Opportunity for secondary economic gain Well organized political support o Industry Lobby o Public Health Lobby * o Provincial Medical Associations * o Child Health Advocates Aligned political commitments / priorities o Easily executed health promotion / disease prevention promises Leading cross-jurisdictional comparators Receptive public Compelling policy narrative
40 Vaccine Decisions (2) Procurement Public Works and Government Services Canada (PWGSC) Federal Monitoring for Post-Market Vaccine Safety Health Canada (Biologics and Genetic Therapies Directorate) Federal Surveillance for Vaccine-Preventable Disease Ministriesof Health Provincial/Territorial Measuring Vaccine Coverage Ministries of Health Provincial Territorial
41 Measuring Vaccine Coverage Ministries of Health Provincial/Territorial 13 systems to measure vaccine coverage o Varied delivery systems o Varied IT capacity o Varied requirements regarding vaccine coverage reporting o Varied province-level health services research infrastructure New horizon = PANORAMA o Common data definitions o National-level public health data collection (partial participation)* Opportunity for important health services research o Need to discern differences in outcomes across jurisdictions
42 Objectives Structure of Canadian health care system Processes supporting evidence-informed policy Challenges with evidence-informed policy-making Realities of priority setting in publicly-funded health care systems
How new vaccines are introduced into programs & why programs differ across Canada
How new vaccines are introduced into programs & why programs differ across Canada Western Canada Immunization Forum January 30, 2018 Monika Naus MD MHSc FRCPC FACPM BC Centre for Disease Control School
HPV Immunization, Canadian Perspective
HPV Immunization, Canadian Perspective Mahnaz FarhangMehr Interim Director, Immunization Division Center for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada Outline Background,
VACCINES FOR ADULTS. Developing an Underutilised Health Resource. 13 November 2007
VACCINES FOR ADULTS Developing an Underutilised Health Resource 13 November 2007 OUTLINE background to adult immunisation in Canada roles and recommendations of immunisation advisory committees in Canada
The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS
1 The Federal Initiative To Address HIV/AIDS in Canada Canada s Domestic Response to HIV/AIDS Presentation to the Northern Dimension Partnership On Public Health and Social Well-being March 18, 2009 Ottawa,
Pandemic Influenza Planning Considerations in On-reserve First Nations Communities
B Pandemic Influenza Planning Considerations in On-reserve First Nations Communities 1. Introduction The national pandemic influenza plan provides a framework that will guide planning in all jurisdictions
Immunization Competencies Education Program
Immunization Competencies Education Program Adapted by: Michael Boivin, B Pharm Susan Bowles, BSc Phm, PharmD, MSc Danielle Grenier, MD, FRCPC Ian Gemmill, MD, CCFP, FCFP, FRCPC Alex Henteleff, BN, Med
Appendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
ANNEX B INFLUENZA PANDEMIC PLANNING CONSIDERATIONS IN ON RESERVE FIRST NATIONS COMMUNITIES
Assembly of First Nations Assemblée des Premières Nations 1 ANNEX B INFLUENZA PANDEMIC PLANNING CONSIDERATIONS IN ON RESERVE FIRST NATIONS COMMUNITIES Presented by the Assembly of First Nations (Kim Barker),
Monitoring of the achievement of the health-related Millennium Development Goals
SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered
Chapter 3: Roles and Responsibilities
Chapter 3: Roles and Responsibilities Chapter 3: Roles and Responsibilities Page 3-1 Chapter 3: Roles and Responsibilities Table of Contents 1.0 Introduction 2.0 International World Health Organization
A Report from the F/P/T Advisory Committee on Population Health and Health Security (ACPHHS) to the Conference of F/P/T Deputy Ministers of Health
No. of Cases 700 600 500 400 300 Haemophilus influenzae type b (Hib) Disease Reported Cases, Canada, 1979-2003* Year Vaccine Introduced 1986: PRP 1988: PRP-D 1991: HbOC/PRP-OMP 1992: PRP-T 200 100 0 1979
Immunization Coverage Report for School Pupils in Ontario School Year
Immunization Coverage Report for School Pupils in Ontario 2016 17 School Year Technical Report August 2018 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and
Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 12 July 2011 Original:
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson
Advocacy Strategy
Advocacy Strategy 2016-2021 September 1, 2016 CONTRIBUTE C1 & C4 1. Executive Summary As Canada s largest Catholic provider of health care with a 150-year legacy of quality, compassionate care Covenant
Vaccine Decision-Making
Key Points Vaccine Decision-Making * Decisions on introducing new vaccines have long-term implications for immunization costs as well as logistics systems and service delivery. The choice of vaccine presentation
Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative. Presentation to Atlantic Directors August 23, 2012
Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative Presentation to Atlantic Directors August 23, 2012 1 2 21 1 9 2 3 EXISTING STATE Nova Scotia has the highest incidence
Fifth report of Committee A
SIXTY-EIGHTH WORLD HEALTH ASSEMBLY (Draft) A68/73 26 May 2015 Fifth report of Committee A (Draft) Committee A held its twelfth and thirteenth meetings on 25 May 2015 under the chairmanship of Dr Eduardo
Recommendations for Human Papillomavirus Vaccination Provincial Infectious Diseases Advisory Committee on Immunization
Recommendations for Human Papillomavirus Vaccination Provincial Infectious Diseases Advisory Committee on Immunization June 11, 2012 i This document was prepared for the Provincial Infectious Diseases
The G8 Dementia Summit: A Giant Step Forward for Dementia
The G8 Dementia Summit: A Giant Step Forward for Dementia January 28, 2014 Mimi Lowi-Young, M.H.A, Dip Bus. Admin., FACHE, FCCHL Chief Executive Officer, Alzheimer Society of Canada Overview 1. Background
Resolutions of the 50 th East, Central and Southern African Health Ministers Conference
50 th ECSA HMC East, Central and Southern African Health Community ECSA-HC February 2010 Resolutions of the 50 th East, Central and Southern African Health Ministers Conference Serena Hotel, Kampala Uganda
CPhA PRE-BUDGET CONSULTATION BRIEF Prescriptions for a healthy and productive Canada
CPhA PRE-BUDGET CONSULTATION BRIEF 2018 Prescriptions for a healthy and productive Canada Introduction On behalf of the Canadian Pharmacists Association (CPhA) and Canada s 40,000 pharmacists, we are pleased
A1. Does your government have a formal, written diabetes policy or strategy?
Survey of Diabetes Programs and Services in Canada Canadian Diabetes Association Diabetes Progress Report A1. Does your government have a formal, written diabetes policy or strategy? Yes. In October 2002,
The Canadian Strategy for Cancer Control: A Cancer Plan for Canada
The Canadian Strategy for Cancer Control: A Cancer Plan for Canada July, 2006 Discussion Paper This document has been prepared by the CSCC Governing Council and summarizes the Five-Year Business Plan of
An Investment in Public Health: An Investment in Canada s Future Prosperity
An Investment in Public Health: An Investment in Canada s Future Prosperity Pre-Budget Consultation Brief to the House of Commons Standing Committee on Finance Prepared by the Canadian Public Health Association
O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery
O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Delivery CPHA 2016 Health Protection June 14, 2016 Authors Rosalie Tuchscherer, Saskatchewan Ministry of Health Jill Reedijk, British
Brief. Ministry of Health and Long-Term Care. Health Based Allocation Model (HBAM) Funding Formula for LHINs. Mental Health & Addictions Sector
Brief to the Ministry of Health and Long-Term Care on the proposed Health Based Allocation Model (HBAM) Funding Formula for LHINs with respect to the Mental Health & Addictions Sector The Ministry of Health
What are the new active vaccine recommendations in the Canadian Immunization Guide?
154 CCDR 17 April 2014 Volume 40-8 https://doi.org/10.14745/ccdr.v40i08a03 1 What are the new active vaccine recommendations in the Canadian Immunization Guide? Warshawsky B 1 and Gemmill I 2 on behalf
GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012
GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 ADRESSING CHALLENGES TO SUSTAINABLE NEW VACCINE INTRODUCTION: PERSPECTIVE FROM MONGOLIA N.UDVAL, MD, Sc D MINISTER OF HEALTH MONGOLIA CONTENT
HEALTHY CANADIANS AND SUSTAINED ECONOMIC RECOVERY: PREDICTABLE VACCINE FUNDING IN CANADA
HEALTHY CANADIANS AND SUSTAINED ECONOMIC RECOVERY: PREDICTABLE VACCINE FUNDING IN CANADA HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE 2012 PRE-BUDGET CONSULTATIONS EXECUTIVE SUMMARY Merck Canada is pleased
Introduction and overview of the program; new vaccine pipeline and prioritization process
Immunization for the Modern Family: Western Canada Immunization Forum 2011 Introduction and overview of the program; new vaccine pipeline and prioritization process Monika Naus, MD, MHSc, FRCPC, FACPM
3.04. Immunization. Chapter 3 Section. Background. Ministry of Health and Long-Term Care
Chapter 3 Section 3.04 Ministry of Health and Long-Term Care Immunization Background Immunization with vaccines can reduce or eliminate the prevalence of many infectious diseases and therefore help maintain
Immunization Competencies Education Program
Immunization Competencies Education Program Adapted by: Michael Boivin, B Pharm Susan Bowles, BSc Phm, PharmD, MSc Danielle Grenier, MD, FRCPC Ian Gemmill, MD, CCFP, FCFP, FRCPC Alex Henteleff, BN, Med
Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 25 April 2014 Original:
How does Gavi make vaccine investment decisions?
How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)
Changing the prevention paradigm for the future what Europe can do
November 3rd, 2014 Honorable Beatrice Lorenzin, Minister of Health of Italy Italian Presidency of the EU Council Conference/Meeting The State of Health of Vaccination in the EU: where do we stand, where
Review of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
What is to be done to respond to country needs and comply with WHA and SAGE recommendations?
New vaccine introduction in MIC: current initiatives to address financial challenges What is to be done to respond to country needs and comply with WHA and SAGE recommendations? 1 Plan SAGE recommendations
The Sustainable Development Goals: The implications for health post Ties Boerma, Director of Information, Evidence and Research, WHO, Geneva
The Sustainable Development Goals: The implications for health post-2015 Ties Boerma, Director of Information, Evidence and Research, WHO, Geneva Outline SDGs: general process and features 2030 Agenda:
Human Papillomavirus (HPV) Vaccination Program Update
STAFF REPORT ACTION REQUIRED Human Papillomavirus (HPV) Vaccination Program Update Date: September 4, 2008 To: From: Wards: Board of Health Medical Officer of Health All Reference Number: SUMMARY The Human
Strengthening Health Systems and Blood Services
Strengthening Health Systems and Blood Services through a Primary Health Care Approach Dr Neelam Dhingra Coordinator Blood Transfusion safety WHO-HQ, Geneva Outline of the Presentation Blood Transfusion
Disclosure Statement. I have no affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.
Disclosure Statement I have no affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization. 1 What s new with NACI? Dr. Caroline Quach, NACI Chair Dr. Matthew
World Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
Normalization and informed decision making in public health programs: A case study of HPV vaccination in Canada. Brenda Wilson Tanya Navaneelan
Normalization and informed decision making in public health programs: A case study of HPV vaccination in Canada Brenda Wilson Tanya Navaneelan Acknowledgements Julian Little, Beth Potter, Department of
Thailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand
Thailand Expanded Program on Immunization Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand Outline Expanded Program on Immunization Organization Immunization
Background Paper for the OTDT Committees
Background Paper for the OTDT Committees Organs and Tissues Donation and Transplantation (OTDT) Listing of Key Government Reports Contents 1. Introduction... 2 A. Background... 2 2. Public Recommendation
Update of The National Vaccine Plan
Update of The National Vaccine Plan Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services Presentation Outline Statutory basis for the National Vaccine Program
Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs
Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs Chris Taylor, Senior Director, Viral Hepatitis United States Conference on AIDS: Hepatitis Pathway September 10,
Vaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013
Vaccine Safety: Its everyone s business! PHO Rounds: Nov 19, 2013 Tara Harris, Nurse Consultant Shelley Deeks, Medical Director Immunization and Vaccine Preventable Diseases 1 Learning objectives 1. Describe
Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores
Capital Markets Bulletin September 2017 Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores On September 8, 2017, Ontario s provincial government unveiled its much-anticipated
Chronic Non Communicable Disease. The Grenada Experience.
Chronic Non Communicable Disease The Grenada Experience. Core Values Government of Grenada views health A basic human right A vehicle for economic growth and social development. Emphasis Primary prevention
COMMUNICABLE DISEASE REPORT
COMMUNICABLE DISEASE REPORT Quarterly Report Volume 31, Number 1 2014 June Immunization Programs in NEWFOUNDLAND AND LABRADOR Routine Immunization Schedule (2 months - 6 years) July 1, 2014 In Newfoundland
Report to the Board 6-7 June 2018
6-7 June 2018 SUBJECT: VACCINE INVESTMENT STRATEGY: SHORT LIST Agenda item: 07 Category: For Decision Section A: Introduction This report presents outcomes of the Phase II analyses for the Vaccine Investment
POLICY AND ECONOMIC CONSIDERATIONS FOR FRAILTY SCREENING IN THE CANADIAN HEALTHCARE SYSTEM
POLICY AND ECONOMIC CONSIDERATIONS FOR FRAILTY SCREENING IN THE CANADIAN HEALTHCARE SYSTEM Executive Summary Kelly Grimes, Jennifer Kitts, Bill Tholl May 2, 2016 Executive Summary There are significant
Will the Canadian Government s Commitment to Use a Gender-based Analysis Result in Public Policies Reflecting the Diversity of Women s Lives?
Promoting social change through policy-based research in women s health Will the Canadian Government s Commitment to Use a Gender-based Analysis Result in Public Policies Reflecting the Diversity of Women
Addressing Delay 2: Maternity Waiting Shelters to Improve Access to Services in Zambia
Addressing Delay 2: Maternity Waiting Shelters to Improve Access to Services in Zambia Julie Becker May 5, 2014 What Did we Learn, How to Improve MSD for Mothers: A Brief Overview MSD for Mothers Focus
Measles Outbreak 2015 and Ontario's Immunization System
HL5.3 STAFF REPORT ACTION REQUIRED Measles Outbreak 2015 and Ontario's Immunization System Date: June 11, 2015 To: From: Wards: Board of Health Medical Officer of Health All Reference Number: SUMMARY In
Lessons from the frontlines:
Lessons from the frontlines: A collaborative report on H1N1 from Canadian Medical Association The College of Family Physicians of Canada National Specialty Society of Community Medicine July 2010 The Canadian
2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS
2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS MEMBERSHIP SERVICES DIVISION Leadership Development and Member Engagement: Ensures AFP services to members and provides support to chapters and chapter services.
ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA
ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA Wherever inequality lives, there stands a girl or woman able to turn the tide of adversity into a tidal wave
From Vaccine Development to Policy: A Brief Review of WHO Vaccine-Related Activities and Advisory Processes (2017)
1. Introduction From Vaccine Development to Policy: A Brief Review of WHO Vaccine-Related Activities and Advisory Processes (2017) To help achieve the implementation of the Global Vaccine Action Plan (GVAP),
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
Gavi initiatives for improving vaccine supply
Gavi initiatives for improving vaccine supply Melissa Malhame DCVMN, 28 October 2014 A world free from vaccine preventable diseases www.gavi.org Agenda 1. Gavi Strategy 2011-2015, and supply and procurement
Intensifying our efforts towards a world free of the avoidable burden of NCDs
OUTCOME DOCUMENT OF THE HIGH-LEVEL MEETING OF THE GENERAL ASSEMBLY ON THE REVIEW OF THE PROGRESS ACHIEVED IN THE PREVENTION AND CONTROL OF NON- COMMUNICABLE DISEASES Revised version dated 3 July 2014 11.50
ACIP Developing Vaccine Recommendations and Policy in the US
VPD: Policy, Practice, Preparedness Conference An inside View of ACIP Vaccine Recommendations Larry K, Pickering, MD, FAAP, FIDSA July 23, 2012 National Center for Immunization & Respiratory Diseases Office
Building and Sustaining Political Commitment for Nutrition Action Lao PDR
SUN Movement 23 rd Series of Country Network Teleconferences- Building and Sustaining Political Commitment for Nutrition Action Lao PDR SUN is a unique Movement founded on the principle that all people
CHAPTER 4: Population-level interventions
CHAPTER 4: Population-level interventions Population-level interventions refer to policies and programs that are applied to entire populations to promote better health outcomes. In this chapter, we describe
SCHOOL- BASED TYPHOID VACCINATION PROGRAM IN KARACHI: POLICY IMPLICATIONS FOR TYPHOID CONTROL
SCHOOL- BASED TYPHOID VACCINATION PROGRAM IN KARACHI: POLICY IMPLICATIONS FOR TYPHOID CONTROL G. Mustafa 1, R. Tahir 1, W. Ahmed 1, M.S. Malik 1, M. I. Khan 2, R.L. Ochiai 2, I.Haq 3, S.B.Soofi 3, Z.A.Bhutta
2018/ /21 SERVICE PLAN
Ministry of Mental Health and Addictions 2018/19 2020/21 SERVICE PLAN February 2018 For more information on the Ministry of Mental Health and Addictions contact: Ministry of Mental Health and Addictions
BC First Nations Panorama Implementation Project (FN PIP) WE WOULD LIKE TO HEAR FROM YOU!
BC First Nations Panorama Implementation Project (FN PIP) WE WOULD LIKE TO HEAR FROM YOU! Dear BC First Nations Public Health Service Providers, British Columbia is getting ready to start using a new public
Gavi s Vaccine Investment Strategy
Gavi s Vaccine Investment Strategy Judith Kallenberg, Head of Policy WHO Product Development for Vaccines Advisory Committee Meeting Geneva, Switzerland, 7-9 September 2015 www.gavi.org Vaccine Investment
Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018
The Minister s Opioid Emergency Response Commission was established May 31, 2017 to support the Government of Alberta s urgent response to the opioid crisis. As part of its mandate, the Commission is responsible
Gavi Alliance Strategy : Goal level indicators and disease dashboard
Gavi Alliance Strategy 2016-2020: Goal level indicators and disease dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June 2015, Geneva Reach every child www.gavi.org Strategic enablers Goal-level
General Assembly. United Nations A/65/L.27. Global health and foreign policy. Distr.: Limited 1 December Original: English
United Nations A/65/L.27 General Assembly Distr.: Limited 1 December 2010 Original: English Sixty-fifth session Agenda item 124 Global health and foreign policy Andorra, Argentina, Australia, Belgium,
AAP Immunization Initiatives JILL HERNANDEZ, MPH
AAP Immunization Initiatives JILL HERNANDEZ, MPH AAP Structure The AAP Today 62,000 members 10 districts 66 state/local chapters 26 national committees 50 sections 11 councils 500 staff Illinois, Washington
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C Dr. Doug Sider, Medical Director, Public Health Ontario Dr. Peggy Millson, Professor Emeritus, Dalla Lana School
Formal Reference Groups, Committees and Meetings
Formal Reference Groups, s and Meetings Advocacy and representation Lead agency and meeting Meeting summary NADA and sector NGO Advisory Drug and Alcohol Program Council Program Council Quality in Treatment
Evaluation of Immunization and Respiratory Infectious Disease Activities at the Public Health Agency of Canada to
Health Canada and the Public Health Agency of Canada Santé Canada et l Agence de la santé publique du Canada Evaluation of Immunization and Respiratory Infectious Disease Activities at the Public Health
THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH ( )
THE GLOBAL STRATEGY FOR WOMEN S, CHILDREN S AND ADOLESCENTS HEALTH (2016-2030) SURVIVE THRIVE TRANSFORM AT A GLANCE SURVIVE THRIVE TRANSFORM The Global Strategy for Women s, Children s and Adolescents
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference
Ministry of Health and Long-Term Care Presentation to the CPSO Methadone Prescribers Conference November 9, 2012 Overview Minister s Expert Working Group on Narcotic Addiction OxyNEO and OxyContin: Changes
STRATEGIC DIRECTIONS AND FUTURE ACTIONS: Healthy Aging and Continuing Care in Alberta
STRATEGIC DIRECTIONS AND FUTURE ACTIONS: Healthy Aging and Continuing Care in Alberta APRIL 2000 For additional copies of this document, or for further information, contact: Communications Branch Alberta
3. CONCLUSIONS AND RECOMMENDATIONS
3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the
Actions Taken and Future Directions 2011
Actions Taken and Future Directions 2011 Curbing Childhood Obesity: A Federal, Provincial and Territorial Framework for Action to Promote Healthy Weights November 25, 2011 Actions Taken and Future Directions
PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA
PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA PROF AUSTINE OMOIGBERALE MBBS, FWACP(Paed) Professor of Paediatrics President PAN PAEDIATRIC ASSOCIATION OF NIGERIA BACKGROUND
Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030
Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework
OBSERVATIONS: WHO GLOBAL CONFERENCE ON NCDS PURSUING POLICY COHERENCE TO ACHIEVE SDG TARGET 3.4 ON NCDS (MONTEVIDEO, URUGUAY, OCTOBER 2017)
OBSERVATIONS: WHO GLOBAL CONFERENCE ON NCDS PURSUING POLICY COHERENCE TO ACHIEVE SDG TARGET 3.4 ON NCDS (MONTEVIDEO, URUGUAY, 18-20 OCTOBER 2017) [Escriba aquí] DR. GABRIEL J O SHEA CUEVAS DRA. CELINA
THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY
THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY Uganda AIDS Commission February 1993 EXECUTIVE SUMMARY 1. Introduction Background Information to AIDS in Uganda 1. AIDS was first
Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules
Newfoundland and Labrador Immunization Manual Section 2... 2.1 Routine and Delayed Immunization Schedules for Infants and Children... 2.2 Recommended Immunizations for Adults... 2.3 (Provinces and Territories)...
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact
Program Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective IAIM Regional Meeting for the Americas and Europe 1 February 2017 Anupama Tantri
OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health
OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents Health Every Woman Every Child 2016 OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents
THE PMNCH 2012 REPORT ANALYSING PROGRESS ON COMMITMENTS TO THE GLOBAL STRATEGY FOR WOMEN S AND CHILDREN S HEALTH *****
THE PMNCH 2012 REPORT ANALYSING PROGRESS ON COMMITMENTS TO THE GLOBAL STRATEGY FOR WOMEN S AND CHILDREN S HEALTH ***** ONLINE QUESTIONNAIRE International Federation of Gynecology and Obstetrics 1. Does
Overview of M2K Policy Recommendations from Across Canada and Areas of Alignment
Overview of M2K Policy Recommendations from Across Canada and Areas of Alignment Monique Potvin Kent, PhD Interdisciplinary School of Health Sciences University of Ottawa June 5, 2014 PLAN for TODAY 1)Research
Countdown to 2015: tracking progress, fostering accountability
Countdown to 2015: tracking progress, fostering accountability Countdown to 2015 is a global movement to track, stimulate and support country progress towards achieving the health-related Millennium Development
Cancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
NACCHO COMMITTEES AND WORKGROUPS
NACCHO COMMITTEES AND WORKGROUPS NACCHO's advisory groups are a primary and recognized vehicle for identifying the opportunities and challenges facing local health departments and the field of public health
The Human Papillomavirus Vaccine
The Human Papillomavirus Vaccine Publication No. 2011-114-E 9 November 2011 Sonya Norris Social Affairs Division Parliamentary Information and Research Service The Human Papillomavirus Vaccine (Background
Draft resolution submitted by the President of the General Assembly
United Nations A/68/L.53 General Assembly Distr.: Limited 7 July 2014 Original: English Sixty-eighth session Agenda item 118 Follow-up to the outcome of the Millennium Summit Draft resolution submitted